Fred Hutch President and Director Dr. Tom Lynch led a conversation with Drs. Trevor Bedford, Joshua Hill and Alpana Waghmare about viral variants, vaccines and kids, new treatments, considerations for cancer patients and more.
In early August, scientists on the front lines of COVID-19 provided an up-to-the-minute briefing on the pandemic. Moderated by Dr. Tom Lynch, Fred Hutchinson Cancer Research Center president and director, the virtual event was conceived and planned in July when the virus was retreating and public health restrictions were easing.
"This virus continues to evolve and bring new risks, and the delta variant is the latest curveball," said Lynch, holder of the Raisbeck Endowed Chair. Instead of the original topic, he led a discussion with the panelists about variants, vaccines, and how to respond to a changing virus that is again disrupting plans to return to workplaces, schools and other activities.
Here are a few of the top messages from the wide-ranging discussion.
More than 20% of Hutch researchers are working on projects related to COVID-19. They are seeking to understand its spread, develop vaccines and treatments, and uncover how the virus attacks our immune systems.
The next Science Says will be Oct. 7 at 1 p.m. PDT. Log in to learn how the Hutch is taking on solid tumors using expertise and methods developed to cure blood cancers.
Every dollar counts. Please support lifesaving research today.
For the Media